UK markets closed

Boston Scientific Corporation (0HOY.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
72.89+1.31 (+1.83%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 338.01%
S&P500 52-week change 322.43%
52-week high 372.94
52-week low 347.37
50-day moving average 363.51
200-day moving average 355.52

Share statistics

Avg vol (3-month) 326.83k
Avg vol (10-day) 345.44k
Shares outstanding 51.38B
Implied shares outstanding 6N/A
Float 81.47B
% held by insiders 10.19%
% held by institutions 194.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.05%
Operating margin (ttm)17.97%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)9.25%

Income statement

Revenue (ttm)14.71B
Revenue per share (ttm)10.06
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA 3.74B
Net income avi to common (ttm)1.76B
Diluted EPS (ttm)0.53
Quarterly earnings growth (yoy)57.30%

Balance sheet

Total cash (mrq)2.33B
Total cash per share (mrq)1.58
Total debt (mrq)11B
Total debt/equity (mrq)54.55%
Current ratio (mrq)1.66
Book value per share (mrq)13.56

Cash flow statement

Operating cash flow (ttm)2.48B
Levered free cash flow (ttm)1.65B